(Q35691678)

9 August 2017

1 reference

title

Quality of care indicators for gout management (English)

1 reference

9 August 2017

0 references

Jeroan J Allison

5

0 references

Ted R Mikuls

1

object named as

Ted R Mikuls

1 reference

9 August 2017

Catherine H MacLean

2

1 reference

9 August 2017

Jason Olivieri

3

1 reference

9 August 2017

Fausto Patino

4

1 reference

9 August 2017

John T Farrar

6

1 reference

9 August 2017

Warren B Bilker

7

1 reference

9 August 2017

Kenneth G Saag

8

1 reference

9 August 2017

publication date

1 March 2004

1 reference

9 August 2017

published in

Arthritis & Rheumatology

1 reference

9 August 2017

volume

50

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

937-943

1 reference

Assessing care of vulnerable elders: methods for developing quality indicators

9 August 2017

cites work

1 reference

Quality indicators for the management of osteoarthritis in vulnerable elders

21 January 2018

1 reference

Quality indicators for the management of heart failure in vulnerable elders

21 January 2018

1 reference

Quality indicators for dementia in vulnerable community-dwelling and hospitalized elders.

21 January 2018

1 reference

Quality indicators for the management of osteoporosis in vulnerable elders

21 January 2018

1 reference

Quality indicators for prevention and management of pressure ulcers in vulnerable elders

21 January 2018

1 reference

Quality indicators for the management of urinary incontinence in vulnerable community-dwelling elders.

21 January 2018

1 reference

Does colchicine work? The results of the first controlled study in acute gout.

21 January 2018

1 reference

Comparison of allopurinol and probenecid

21 January 2018

1 reference

Qualitative Research: Consensus methods for medical and health services research

21 January 2018

1 reference

Allopurinol Associated Hypersensitivity Reactions: Cutaneous and Renal Manifestations

21 January 2018

1 reference

Treatment of gout with allopurinol. A study of 106 cases

21 January 2018

1 reference

Treatment of Gout with Allopurinol and Sulphinpyrazone in Combination and with Allopurinol Alone

21 January 2018

1 reference

Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion

21 January 2018

1 reference

The Treatment of Acute Gout with Naproxen

21 January 2018

1 reference

Double-blind trial of flurbiprofen and phenylbutazone in acute gouty arthritis

21 January 2018

1 reference

A controlled study of the effect of long term allopurinol treatment on renal function in gout

21 January 2018

1 reference

Development of a quality of care measurement system for children and adolescents. Methodological considerations and comparisons with a system for adult women

21 January 2018

1 reference

The use of sulfinpyrazone in the treatment of gout

21 January 2018

1 reference

THE EFFECTIVENESS OF THE XANTHINE OXIDASE INHIBITOR ALLOPURINOL IN THE TREATMENT OF GOUT

21 January 2018

1 reference

Benzbromarone as a long-term uricosuric agent

21 January 2018

1 reference

Treatment of Gout and Hyperuricaemia by Benzbromarone Ethyl 2 (Dibromo -3,5 Hydroxy - 4 Benzoyl) - 3 Benzofuran

21 January 2018

1 reference

The action of benzbromarone in relation to age, sex and accompanying diseases

21 January 2018

1 reference

Treatment of acute gout with injection of colchicine

21 January 2018

1 reference

Phenylbutazone (butazolidin) in rheumatoid arthritis and gout

21 January 2018

1 reference

Double-blind trial of feprazone and phenylbutazone in acute gout

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.20102

1 reference

9 August 2017

1 reference